PACT Pharma Overview

  • Year Founded
  • 2016

Year Founded

  • Status
  • Out of Business

  • Employees
  • 134

Employees

  • Latest Deal Type
  • Out of Business

PACT Pharma General Information

Description

Developer of personalized adoptive T-cell therapies designed to reprogram the immune system to target and eradicate cancer. The company's therapies help in the identification of neo-epitopes that serve as private mutations for cancer and create an opportunity to engineer autologous T cells that target and kill tumors expressing these neo-antigens, enabling physicians to recognize and remove each patient's cancer cells.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • 2 Corporate Drive
  • South San Francisco, CA 94080
  • United States
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Vertical(s)
Corporate Office
  • 2 Corporate Drive
  • South San Francisco, CA 94080
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

PACT Pharma Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Out of Business 29-Sep-2023 Completed Out of Business
3. Later Stage VC (Series C) 10-Jan-2020 Completed Generating Revenue
2. Early Stage VC (Series B) 25-May-2018 $95M $127M Completed Clinical Trials - Phase 1
1. Early Stage VC (Series A) 20-Dec-2016 $31.7M $31.7M Completed Clinical Trials - Phase 1
To view PACT Pharma’s complete valuation and funding history, request access »

PACT Pharma Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series C
Series B
Series A 29,999,999 $0.000100 $0.08 $1 $1 1x $1 20.47%
To view PACT Pharma’s complete cap table history, request access »

PACT Pharma Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of personalized adoptive T-cell therapies designed to reprogram the immune system to target and eradicate canc
Biotechnology
South San Francisco, CA
134 As of 2022

Cambridge, MA
 

South San Francisco, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

PACT Pharma Competitors (14)

One of PACT Pharma’s 14 competitors is Zumutor Biologics, a Venture Capital-Backed company based in Cambridge, MA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Zumutor Biologics Venture Capital-Backed Cambridge, MA
ArsenalBio Venture Capital-Backed South San Francisco, CA
Allogene Therapeutics Formerly VC-backed South San Francisco, CA
Nkarta Therapeutics Formerly VC-backed South San Francisco, CA
TScan Therapeutics Formerly VC-backed Waltham, MA
You’re viewing 5 of 14 competitors. Get the full list »

PACT Pharma Patents

PACT Pharma Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2023064242-A1 Compositions and methods for isolating t cell receptors (tcrs) and cells expressing the same Inactive 12-Oct-2021
JP-2024522758-A Improved t cell receptor sequencing method Pending 18-Jun-2021
AU-2022294088-A1 Methods for improved t cell receptor sequencing Pending 18-Jun-2021
CA-3222935-A1 Methods for improved t cell receptor sequencing Pending 18-Jun-2021
WO-2022266450-A1 Methods for improved t cell receptor sequencing Inactive 18-Jun-2021 C12Q1/6869
To view PACT Pharma’s complete patent history, request access »

PACT Pharma Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

PACT Pharma Investments (1)

PACT Pharma’s most recent deal was a Early Stage VC with OGD2 Pharma for . The deal was made on 07-Oct-2016.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
OGD2 Pharma 07-Oct-2016 Early Stage VC Drug Discovery
To view PACT Pharma’s complete investments history, request access »

PACT Pharma FAQs

  • When was PACT Pharma founded?

    PACT Pharma was founded in 2016.

  • Where is PACT Pharma headquartered?

    PACT Pharma is headquartered in South San Francisco, CA.

  • What is the size of PACT Pharma?

    PACT Pharma has 134 total employees.

  • What industry is PACT Pharma in?

    PACT Pharma’s primary industry is Biotechnology.

  • Is PACT Pharma a private or public company?

    PACT Pharma is a Private company.

  • What is PACT Pharma’s current revenue?

    The current revenue for PACT Pharma is .

  • How much funding has PACT Pharma raised over time?

    PACT Pharma has raised $202M.

  • Who are PACT Pharma’s competitors?

    Zumutor Biologics, ArsenalBio, Allogene Therapeutics, Nkarta Therapeutics, and TScan Therapeutics are some of the 14 competitors of PACT Pharma.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process